Skip to content

Throwing Velocity and Patient Reported Outcomes in Elite Level Handball Players After Completion of Shoulder-Pacemaker Strength Training

Throwing Velocity and Patient Reported Outcomes in Elite Level Handball Players After Completion of Shoulder-Pacemaker Strength Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06459258
Enrollment
14
Registered
2024-06-14
Start date
2023-03-01
Completion date
2024-06-07
Last updated
2024-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Dislocation

Keywords

Motion-Triggered Neuromuscular Electrical Stimulation-Enhanced Strength Training

Brief summary

The successful application of treatment protocols using motion-triggered neuromuscular electrical stimulation (NMES) for treatment-resistant functional posterior shoulder instability was recently demonstrated. The purpose of this study is to evaluate the concept of a motion-triggered NMES training protocol through objective clinical outcome parameters and its impact on external rotational (ER) shoulder strength and throwing velocity in healthy, elite-level handball players.

Detailed description

The aim of this study is to evaluate the concept of a motion-triggered NMES training protocol through objective clinical outcome parameters and its impact on external rotational (ER) shoulder strength and throwing velocity in healthy, elite-level handball players. It is hypothesized that a 6-week motion-triggered NMES shoulder strengthening training protocol in elite-level handball players would lead to an increase in throwing velocity due to an improved motor ability and ER shoulder strength.

Interventions

OTHERMotion-triggered NMES training protocol

Experimental group subjects undergo a motion-triggered NMES shoulder strengthening training program (3x/week, 30 minutes for 6 weeks) using the Shoulder Pacemaker (NCS Lab Srl, Modena, Italy), a motion activated stimulation device to strengthen muscular disbalances. This is accomplished through varying neuromuscular electrical stimulation intensity based on the angle of motion of the arm producing subtetanic contraction and provoking supraspinal neural adaptations. Electrode placement: electrode 1, inferior to the scapular spine (infraspinatus, teres minor, + posterior deltoid); electrode 2, medial to the medial scapula border (lower trapezius + rhomboids) . Sets x repetitions: 3x20 Levels: Level 1-3; Exercise 1: L1: Supported row, L2: Front raises in 45°, L3 Front raises (thumbs up) Exercise 2: L1: Resisted front raises, L2: Crossbody resisted raises, L3: Crossbody; forehand swing; Exercise 3: L1: Rear dealt fly, L2: Single arm resisted row, L3: Underhand volleyball

OTHERNon-Motion-triggered NMES training protocol

Arm Description: Subjects of the control group undergo a conventional standardized strength training program (3x/week, 30 minutes for 6 weeks) with concentric, eccentric, and functional training exercises.

Sponsors

Austrian Research Group for Regenerative and Orthopedic Medicine
CollaboratorOTHER
Sportorthopädie Zentrum in Wien Hietzing
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Study group allocation is performed in a randomized and examiner-blinded fashion. All study authors and examiners are blinded to the group allocation until completion of data analysis.

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Elite level handball players healthy and actively competing at the time of the study * Patients must be at least 18 years at the time of signing the informed consent * Pregnancy must be ruled out in the case of female participants (e.g., pregnancy test) * Patient must be available for all specified assessments throughout the study duration * All patients are required to give written informed consent before enrollment

Exclusion criteria

* age <18, * history of type I or II shoulder instability according to the Stanmore classification12, * existing pain syndrome (defined by pain at rest or during motion that is not caused by dislocation and impedes training), * recent shoulder surgery (<1 year). * Contraindication to SPM treatment (e.g., cardiac pacemaker) * Neurological disorders or nerve injuries causing the instability * Uncontrolled alcohol or substance abuse

Design outcomes

Primary

MeasureTime frameDescription
Throwing velocity (km*h-1)Baseline to 6-week post-intervention follow-up.the difference in throwing velocity (km\*h-1) from baseline to 6-week post-intervention follow-up.

Secondary

MeasureTime frameDescription
Isometric hand-held dynamometer (HHD) ER and internal rotation (IR) maximal shoulder strengthBaseline to 6-week post-intervention follow-upSecondary outcome was the difference in isometric hand-held dynamometer (HHD) ER and internal rotation (IR) maximal shoulder strength at final follow-up.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026